Inhibitory activities of lansoprazole against respiration in Helicobacter pylori

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 5, 2001, Pages 1522-1527

  Nagata, K ^a   Sone, N ^a   Tamura, T ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; ROTENONE;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; CELL RESPIRATION; DRUG EFFECT; ENZYME ACTIVITY; GROWTH INHIBITION; HELICOBACTER PYLORI; MINIMUM INHIBITORY CONCENTRATION; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY CHAIN; STOMACH MUCOSA;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADENOSINE TRIPHOSPHATE; ANTI-ULCER AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HELICOBACTER PYLORI; HUMANS; MICROBIAL SENSITIVITY TESTS; OMEPRAZOLE; OXYGEN;

EID: 0035028470     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.5.1522-1527.2001     Document Type: Article

References (29)

1. Respiration in Helicobacter pylon is carried out by at least two terminal oxidases, one of which is a novel haem-copper oxidase of the cb-type
2. Investigations into the aerobic respiratory chain of Helicobacter pylori
3. Effects of substances inhibiting or uncoupling respiratory-chain phosphorylation of Helicobacter pylori
4. Partial characterization and effect of omeprazole on ATPase activity in Helicobacter pylori by using permeabilized cells
5. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation
6. Kinetics of substrate oxidation by whole cells and cell membranes of Helicobacter pylori
7. Characterization of the respiratory chain of Helicobacter pylori
8. Identification of a formate dehydrogenase-associated cytochrome c-553 in Helicobacter pylori
9. +)ATPase
10. Does NADH play a central role in energy metabolism in Helicobacter pylori?
11. Novel antibiotics susceptibility tests by the ATP-bioluminescence method using filamentous cell treatment
12. Helicobacter pylori porCDAB and oorDABC genes encode distinct pyruvate: Flavodoxin and 2-oxoglutarate: Acceptor oxidoreductases which mediate electron transport to NADP
13. Lansoprazole, novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori
14. Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication
15. The physiology and metabolism of the human gastric pathogen Helicobacter pylori
16. Metabolism and genetics of Helicobacter pylori
17. Identification and characterization of an ATPase system of Helicobacter pylori and the effect of proton pump inhibitors
18. Pyruvate metabolism in Helicobacter pylori
19. Oxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitro
20. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: Unique action selective for H. pylori cells
21. Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: Inhibition of growth is not related to inhibition of urease
22. A cb-type cytochrome-c oxidase terminates the respiratory chain in Helicobacter pylori
23. Helicobacter pylori generates superoxide radicals and modulates nitric oxide metabolism
24. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori
25. Helicobacter pylori infection and the risk of gastric carcinoma
26. Helicobacter pylori infection and gastric lymphoma
27. Is Helicobacter pylori a cause of duodenal ulcer? A methodologic critique of current evidence
28. Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylori
29. The complete genome sequence of the gastric pathogen Helicobacter pylori